Neville Everett 4

4 · Cigna Group · Filed Mar 3, 2026

Form 4

Period: 2026-02-27

See Remarks

Transactions

Award
Common Stock, $.01 Par Value
[F1]
2026-02-27+2,602→ 6,111 total
Award
Common Stock, $.01 Par Value
[F2]
2026-02-27+2,678→ 8,789 total
Tax Payment
Common Stock, $.01 Par Value
[F3]
2026-02-27$287.55/sh−883$253,907→ 7,906 total
Tax Payment
Common Stock, $.01 Par Value
[F4]
2026-02-27$287.55/sh−517$148,663→ 7,389 total
Sale
Common Stock, $.01 Par Value
[F5]
2026-03-02$288.91/sh−1,719$496,636→ 5,670 total
Award
Employee Stock Option (Right to Buy)
[F6]
2026-02-27+4,127→ 4,127 total
Exercise: $287.55From: 2027-03-01Exp: 2036-02-27→ Common Stock, $.01 Par Value (4,127 underlying)

Footnotes (6)

[F1]The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
[F2]These restricted shares vest in three equal annual installments beginning March 1, 2027.
[F3]Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
[F4]Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
[F5]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2025.
[F6]This option vests in three equal annual installments beginning March 1, 2027.

Signature

Tyler Gratton, attorney-in-fact|2026-03-02

Documents

1 file